Cannabis Stocks Dive
New York hits $1B cannabis sales, Ukraine registers first medical product. Updates on DoorDash, Tilray, Agrify and more.
Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. New York released updated ...
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...
A Drug Enforcement Administration (DEA) judge has ordered the agency to respond to new allegations that it opposes the Biden ...
Tilray Brands reported 9% YoY revenue growth in Q2 2025 to $210.95 million. Fiscal 2025 guidance remains strong at $950 ...
The DEA rejected a September request from Colorado officials to participate in the United States' historic marijuana ...
Attorneys for a cannabis company and advocacy group that are set to testify in the Drug Enforcement Administration’s (DEA) marijuana rescheduling hearing process beginning this month say new evidence ...
A group of pro-cannabis entities scheduled to present in the forthcoming cannabis rescheduling hearing have filed a new ...
Recreational cannabis is now legal in 24 states and three more could legalize some form of marijuana sales this year. But ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback